Wound Formulary Update 3rd line products
With effect from 16 June 2020 the commonly requested 3rd line wound formulary products have now been added as a separate favourites list. We have gained permission for teams to have a small stock to enable prompt commencement of treatment once advised to use by Tissue Viability. Further stocks can then be requested on a patient by patient basis. Staff are still to seek Tissue Viability approval to use these items.
Audits will be carried out and if there is overstocking or misuse this availability will be stopped.
Please contact tissue viability with any queries: - DCHST.DCHSTissueViability@nhs.net